Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
55.63
+0.77 (1.40%)
At close: Jun 9, 2026, 4:00 PM EDT
56.15
+0.52 (0.93%)
Pre-market: Jun 10, 2026, 8:06 AM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $32.03 billion as of June 10, 2026. Its market cap has increased by 76.34% in one year.
Market Cap
32.03B
Enterprise Value
40.40B
1-Year Change
76.34%
Ranking
Category
Stock Price
$55.63
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $32.03B, an increase of 20.91%. That is a compound annual growth rate of 3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 31.59B | 41.63% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 62.69B |
| argenx SE | 54.50B |
| Alnylam Pharmaceuticals | 39.75B |
| Revolution Medicines | 31.79B |
| BeOne Medicines AG | 29.81B |
| BioNTech SE | 21.87B |
| Insmed | 21.47B |
| Roivant Sciences | 20.89B |